Cardiff Oncology, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cardiff Oncology, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Cardiff Oncology, Inc. Return On Assets for the quarter ending September 30, 2024 was -60.4 %, a 51.3% decline year-over-year.
  • Cardiff Oncology, Inc. annual Return On Assets for 2023 was -44.3 %, a 46% decline from 2022.
  • Cardiff Oncology, Inc. annual Return On Assets for 2022 was -30.3 %, a 51.2% decline from 2021.
  • Cardiff Oncology, Inc. annual Return On Assets for 2021 was -20.1 %, a 43.9% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -44.3 -14 -46% Jan 1, 2023 Dec 31, 2023
2022 -30.3 -10.3 -51.2% Jan 1, 2022 Dec 31, 2022
2021 -20.1 +15.7 +43.9% Jan 1, 2021 Dec 31, 2021
2020 -35.7 +87.2 +70.9% Jan 1, 2020 Dec 31, 2020
2019 -123 -20.5 -20% Jan 1, 2019 Dec 31, 2019
2018 -102 +37.9 +27% Jan 1, 2018 Dec 31, 2018
2017 -140 -69 -96.6% Jan 1, 2017 Dec 31, 2017
2016 -71.4 -25.2 -54.6% Jan 1, 2016 Dec 31, 2016
2015 -46.2 +0.67 +1.43% Jan 1, 2015 Dec 31, 2015
2014 -46.9 +15.2 +24.5% Jan 1, 2014 Dec 31, 2014
2013 -62.1 +85.4 +57.9% Jan 1, 2013 Dec 31, 2013
2012 -147 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.